title: For Autoimmune Ills, Biologics Bring Promise-And Problems.
abstract: The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.
authors.forename: Katherine T
authors.initials: KT
authors.lastname: Adams
authors.forename: Peter
authors.initials: P
authors.lastname: Wehrwein
mesh_terms: D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000627:therapeutic use*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products